{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:59:16Z","timestamp":1792007956369,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,12]]},"DOI":"10.7759\/cureus.105102","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:00:31Z","timestamp":1773324031000},"source":"Crossref","is-referenced-by-count":3,"title":["Contraception in Women With Medical Comorbidities: Clinical Risk Stratification and Individualized Therapeutic Strategies"],"prefix":"10.7759","author":[{"given":"Laura C","family":"Castro Rivero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eimy","family":"Z\u00fa\u00f1iga G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo R","family":"Dur\u00e1n Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.13100","article-title":"Pre-existing conditions and pregnancy: a call to action for multidisciplinary, patient-centred care","volume":"38","author":"Brown HK","year":"2024","unstructured":"Brown HK. Pre-existing conditions and pregnancy: a call to action for multidisciplinary, patient-centred care. Paediatr Perinat Epidemiol. 2024, 38:394-6. 10.1111\/ppe.13100","journal-title":"Paediatr Perinat Epidemiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2022.06.005","article-title":"Double, triple, and quadruple jeopardy: entering pregnancy with two or more multimorbid diagnoses and increased risk of severe maternal morbidity and postpartum readmission","volume":"32","author":"Stanhope KK","year":"2022","unstructured":"Stanhope KK, Worrell N, Jamieson DJ, Geary FH, Boulet SL. Double, triple, and quadruple jeopardy: entering pregnancy with two or more multimorbid diagnoses and increased risk of severe maternal morbidity and postpartum readmission. Womens Health Issues. 2022, 32:607-14. 10.1016\/j.whi.2022.06.005","journal-title":"Womens Health Issues"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.70555","article-title":"Online decision aids for contraceptive choices in women with chronic conditions: a systematic review","volume":"172","author":"Gebresillassie BM","year":"2026","unstructured":"Gebresillassie BM, Doley N, Harris ML. Online decision aids for contraceptive choices in women with chronic conditions: a systematic review. Int J Gynaecol Obstet. 2026, 172:1367-80. 10.1002\/ijgo.70555","journal-title":"Int J Gynaecol Obstet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2021.05.005","article-title":"Women with sickle cell disease report low knowledge and use of long acting reversible contraception","volume":"113","author":"Pecker LH","year":"2021","unstructured":"Pecker LH, Hussain S, Lanzkron S, Tao X, Thaler K, Burke AE, Whaley N. Women with sickle cell disease report low knowledge and use of long acting reversible contraception. J Natl Med Assoc. 2021, 113:552-9. 10.1016\/j.jnma.2021.05.005","journal-title":"J Natl Med Assoc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.14109","article-title":"Continuing to chart the course toward improved reproductive care for women with chronic conditions","volume":"58","author":"Verbiest S","year":"2023","unstructured":"Verbiest S. Continuing to chart the course toward improved reproductive care for women with chronic conditions. Health Serv Res. 2023, 58:195-6. 10.1111\/1475-6773.14109","journal-title":"Health Serv Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.17925\/rmd.2023.2.1.28","article-title":"Challenges in family planning and pregnancy for women with rheumatic diseases","volume":"2","author":"Siegel CH","year":"20231","unstructured":"Siegel CH, Sammaritano LR. Challenges in family planning and pregnancy for women with rheumatic diseases. touchREVIEWS RMD. 20231, 2:1. 10.17925\/rmd.2023.2.1.28","journal-title":"touchREVIEWS RMD"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005980","article-title":"Global burden of maternal disorders and mortality among female individuals aged 15-49 years, 1990-2021","volume":"146","author":"Wang M","year":"2025","unstructured":"Wang M, Zhou L, Tang W, Zou L. Global burden of maternal disorders and mortality among female individuals aged 15-49 years, 1990-2021. Obstet Gynecol. 2025, 146:255-66. 10.1097\/AOG.0000000000005980","journal-title":"Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2020.8536","article-title":"Contraceptive preference, continuation rates, and unintended pregnancies in patients with comorbidities: a prospective cohort study","volume":"30","author":"Leroy-Melamed M","year":"2021","unstructured":"Leroy-Melamed M, Zhao Q, Belmonte MA, Archer J, Peipert JF. Contraceptive preference, continuation rates, and unintended pregnancies in patients with comorbidities: a prospective cohort study. J Womens Health (Larchmt). 2021, 30:1469-75. 10.1089\/jwh.2020.8536","journal-title":"J Womens Health (Larchmt)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-024-02472-9","article-title":"Contraceptive counselling and uptake of contraception among women with cardiovascular diseases: a systematic review and meta-analysis","volume":"113","author":"Feyissa TR","year":"2024","unstructured":"Feyissa TR, Akter S, Harris ML. Contraceptive counselling and uptake of contraception among women with cardiovascular diseases: a systematic review and meta-analysis. Clin Res Cardiol. 2024, 113:1151-70. 10.1007\/s00392-024-02472-9","journal-title":"Clin Res Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-190286","article-title":"Thrombosis in young women on OCPS likely is caused by an unmasking effect of estrogens on underlying thrombophilias","volume":"142","author":"He Z","year":"2023","unstructured":"He Z, Thornhill D, Baird C, et al.. Thrombosis in young women on OCPS likely is caused by an unmasking effect of estrogens on underlying thrombophilias. Blood. 2023, 142:4029. 10.1182\/blood-2023-190286","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021717","article-title":"Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives","volume":"143","author":"Hugon-Rodin J","year":"2024","unstructured":"Hugon-Rodin J, Fontana P, Poncet A, Streuli I, Casini A, Blondon M. Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives. Blood. 2024, 143:70-8. 10.1182\/blood.2023021717","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-021-01147-4","article-title":"Combined oral contraceptive pill-induced hypertension and hypertensive disorders of pregnancy: shared mechanisms and clinical similarities","volume":"23","author":"Gunaratne MD","year":"2021","unstructured":"Gunaratne MD, Thorsteinsdottir B, Garovic VD. Combined oral contraceptive pill-induced hypertension and hypertensive disorders of pregnancy: shared mechanisms and clinical similarities. Curr Hypertens Rep. 2021, 23:29. 10.1007\/s11906-021-01147-4","journal-title":"Curr Hypertens Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000591","article-title":"Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices","volume":"2024","author":"Skeith L","year":"2024","unstructured":"Skeith L, Bates SM. Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices. Hematology Am Soc Hematol Educ Program. 2024, 2024:644-51. 10.1182\/hematology.2024000591","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref14","article-title":"Risk of venous thromboembolic events among obese hormonal contraceptive users","volume":"142","author":"Sridhar DC","year":"20232142","unstructured":"Sridhar DC, Sokkary N, Srivaths LV, et al.. Risk of venous thromboembolic events among obese hormonal contraceptive users. Blood. 20232142, 142:3745.","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: Considerations for prevention and management","volume":"6","author":"LaVasseur C","year":"2022","unstructured":"LaVasseur C, Neukam S, Kartika T, Samuelson Bannow B, Shatzel J, DeLoughery TG. Hormonal therapies and venous thrombosis: Considerations for prevention and management. Res Pract Thromb Haemost. 2022, 6:e12763. 10.1002\/rth2.12763","journal-title":"Res Pract Thromb Haemost"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2022.36.S1.R2290","article-title":"Is estrogen a friend or foe of the human microcirculation throughout the lifespan?","volume":"36","author":"SenthilKumar G","year":"2022","unstructured":"SenthilKumar G, Katunaric B, Bordas\u2010Murphy H, Young M, Buiter NJ, Freed JK. Is estrogen a friend or foe of the human microcirculation throughout the lifespan?. FASEB J. 2022, 36:","journal-title":"FASEB J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14428","article-title":"Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: a randomized clinical trial","volume":"101","author":"Haverinen AH","year":"2022","unstructured":"Haverinen AH, Luiro KM, Szanto T, et al.. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: a randomized clinical trial. Acta Obstet Gynecol Scand. 2022, 101:1102-11. 10.1111\/aogs.14428","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005509","article-title":"Venous thromboembolic risk of estradiol valerate-dienogest compared with ethinyl estradiol-levonorgestrel combined oral contraceptives","volume":"143","author":"Bauerfeind A","year":"2024","unstructured":"Bauerfeind A, von Stockum S, Boehnke T, Heinemann K. Venous thromboembolic risk of estradiol valerate-dienogest compared with ethinyl estradiol-levonorgestrel combined oral contraceptives. Obstet Gynecol. 2024, 143:431-4. 10.1097\/AOG.0000000000005509","journal-title":"Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.07.007","article-title":"High use of estrogen-based contraceptives in young women with inflammatory bowel disease in the United States","volume":"22","author":"Brenner EJ","year":"2024","unstructured":"Brenner EJ, Zhang X, Long MD, Dubinsky MC, Kappelman MD. High use of estrogen-based contraceptives in young women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2024, 22:427-9.e28. 10.1016\/j.cgh.2023.07.007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.70548","article-title":"Cardiovascular risk profile according to World Health Organization medical eligibility criteria for contraceptive use of women using hormonal contraception in Rio de Janeiro state, Brazil","volume":"172","author":"Brusth IP","year":"2026","unstructured":"Brusth IP, Raimundo JM, Blanc HN. Cardiovascular risk profile according to World Health Organization medical eligibility criteria for contraceptive use of women using hormonal contraception in Rio de Janeiro state, Brazil. Int J Gynaecol Obstet. 2026, 172:1675-83. 10.1002\/ijgo.70548","journal-title":"Int J Gynaecol Obstet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2024.05.044","article-title":"Hormonal contraception and medical readiness for female service members","volume":"231","author":"Ricker EA","year":"2024","unstructured":"Ricker EA, Koltun KJ, de la Motte SJ. Hormonal contraception and medical readiness for female service members. Am J Obstet Gynecol. 2024, 231:386-94. 10.1016\/j.ajog.2024.05.044","journal-title":"Am J Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2024.1063","article-title":"Contraception update: a focus on safety and efficacy","volume":"34","author":"Cohn M","year":"2025","unstructured":"Cohn M, Novik R, Batur P. Contraception update: a focus on safety and efficacy. J Womens Health (Larchmt). 2025, 34:280-3. 10.1089\/jwh.2024.1063","journal-title":"J Womens Health (Larchmt)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/circ.147.suppl_1.p390","article-title":"Abstract P390: trends in contraceptive prescribing in women with hypertension from 2017-2022","volume":"147","author":"Sadaniantz K","year":"2023","unstructured":"Sadaniantz K, Wilkie G, Kovell L. Abstract P390: trends in contraceptive prescribing in women with hypertension from 2017-2022. Circulation. 2023, 147:10.1161\/circ.147.suppl_1.p390","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.038659","article-title":"Oral contraceptives, hormone replacement therapy, and stroke risk","volume":"53","author":"Johansson T","year":"2022","unstructured":"Johansson T, Fowler P, Ek WE, Skalkidou A, Karlsson T, Johansson \u00c5. Oral contraceptives, hormone replacement therapy, and stroke risk. Stroke. 2022, 53:3107-15. 10.1161\/STROKEAHA.121.038659","journal-title":"Stroke"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14636","article-title":"Former long-term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: a prospective, population-based cohort study","volume":"102","author":"Mosorin ME","year":"2023","unstructured":"Mosorin ME, Ollila MM, Nordstr\u00f6m T, et al.. Former long-term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: a prospective, population-based cohort study. Acta Obstet Gynecol Scand. 2023, 102:1488-95. 10.1111\/aogs.14636","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-0451","article-title":"Effect of postmenopausal hormone therapy on glucose regulation in women with type 1 or type 2 diabetes: a systematic review and meta-analysis","volume":"46","author":"Speksnijder EM","year":"2023","unstructured":"Speksnijder EM, Ten Noever de Brauw GV, Malekzadeh A, Bisschop PH, Stenvers DJ, Siegelaar SE. Effect of postmenopausal hormone therapy on glucose regulation in women with type 1 or type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2023, 46:1866-75. 10.2337\/dc23-0451","journal-title":"Diabetes Care"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01546-1","article-title":"Menopausal hormone therapy in women with type 2 diabetes mellitus: an updated review","volume":"15","author":"Paschou SA","year":"2024","unstructured":"Paschou SA, Athanasiadou KI, Papanas N. Menopausal hormone therapy in women with type 2 diabetes mellitus: an updated review. Diabetes Ther. 2024, 15:741-8. 10.1007\/s13300-024-01546-1","journal-title":"Diabetes Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14104","article-title":"Obesity and contraceptive use: impact on cardiovascular risk","volume":"9","author":"Rosano GM","year":"2022","unstructured":"Rosano GM, Rodriguez-Martinez MA, Spoletini I, Regidor PA. Obesity and contraceptive use: impact on cardiovascular risk. ESC Heart Fail. 2022, 9:3761-7. 10.1002\/ehf2.14104","journal-title":"ESC Heart Fail"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. Medical Eligibility Criteria for contraceptive use, 2024","volume":"73","author":"Nguyen AT","year":"2024","unstructured":"Nguyen AT, Curtis KM, Tepper NK, et al.. U.S. Medical Eligibility Criteria for contraceptive use, 2024. MMWR Recomm Rep. 2024, 73:1-126. 10.15585\/mmwr.rr7304a1","journal-title":"MMWR Recomm Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-021-01207-7","article-title":"Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis","volume":"18","author":"Zhao H","year":"2021","unstructured":"Zhao H, Xing C, Zhang J, He B. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Reprod Health. 2021, 18:171. 10.1186\/s12978-021-01207-7","journal-title":"Reprod Health"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24803","article-title":"Frequency of contraception documentation in women with systemic lupus erythematosus and rheumatoid arthritis within the Rheumatology Informatics System for Effectiveness Registry","volume":"75","author":"Clowse ME","year":"2023","unstructured":"Clowse ME, Li J, Talabi MB, Eudy AM, Schmajuk G.  Frequency of contraception documentation in women with systemic lupus erythematosus and rheumatoid arthritis within the Rheumatology Informatics System for Effectiveness Registry. Arthritis Care Res (Hoboken). 2023, 75:590-6. 10.1002\/acr.24803","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000823","article-title":"Teratogenic medication use associated with favourable odds of contraception counselling in a cohort of women with systemic lupus erythematosus at a large tertiary academic medical centre","volume":"9","author":"Chandramouli S","year":"2022","unstructured":"Chandramouli S, Alvarez C, Englund TR, Silverstein RG, Sheikh SZ. Teratogenic medication use associated with favourable odds of contraception counselling in a cohort of women with systemic lupus erythematosus at a large tertiary academic medical centre. Lupus Sci Med. 2022, 9:e000823. 10.1136\/lupus-2022-000823","journal-title":"Lupus Sci Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01006-w","article-title":"Which hormones and contraception for women with APS? Exogenous hormone use in women with APS","volume":"23","author":"Sammaritano LR","year":"2021","unstructured":"Sammaritano LR. Which hormones and contraception for women with APS? Exogenous hormone use in women with APS. Curr Rheumatol Rep. 2021, 23:44. 10.1007\/s11926-021-01006-w","journal-title":"Curr Rheumatol Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000001302","article-title":"A pharmacoepidemiologic approach to evaluate real-world effectiveness of hormonal contraceptives in the presence of drug-drug interactions","volume":"32","author":"Sarayani A","year":"2021","unstructured":"Sarayani A, Brown JD, Goodin AJ, et al.. A pharmacoepidemiologic approach to evaluate real-world effectiveness of hormonal contraceptives in the presence of drug-drug interactions. Epidemiology. 2021, 32:268-76. 10.1097\/EDE.0000000000001302","journal-title":"Epidemiology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1167504","article-title":"Women's health, hormonal balance, and personal autonomy","volume":"10","author":"Segarra I","year":"2023","unstructured":"Segarra I, Men\u00e1rguez M, Roqu\u00e9 MV. Women's health, hormonal balance, and personal autonomy. Front Med (Lausanne). 2023, 10:1167504. 10.3389\/fmed.2023.1167504","journal-title":"Front Med (Lausanne)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15259","article-title":"Outcomes after kidney transplant alone in patients with cirrhosis-a case-control study","volume":"38","author":"Nathani RR","year":"2024","unstructured":"Nathani RR, Rutledge SM, Villarroel CS, et al.. Outcomes after kidney transplant alone in patients with cirrhosis-a case-control study. Clin Transplant. 2024, 38:e15259. 10.1111\/ctr.15259","journal-title":"Clin Transplant"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1681\/asn.20223311s1260a","article-title":"Menstruation and Contraception in females with CKD: A Global Mixed-Methods study","volume":"33","author":"Chang DH","year":"20221","unstructured":"Chang DH, Dumanski S, Brennand E, et al.. Menstruation and Contraception in females with CKD: A Global Mixed-Methods study. J Am Soc Nephrol. 20221, 33:260. 10.1681\/asn.20223311s1260a","journal-title":"J Am Soc Nephrol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/LVT.0000000000000524","article-title":"Clinical outcomes in patients with unintended pregnancy after liver transplantation: a multicenter registry cohort study","volume":"31","author":"Walia A","year":"2025","unstructured":"Walia A, Yin O, Coscia L, et al.. Clinical outcomes in patients with unintended pregnancy after liver transplantation: a multicenter registry cohort study. Liver Transpl. 2025, 31:916-23. 10.1097\/LVT.0000000000000524","journal-title":"Liver Transpl"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2020.8910","article-title":"Removing unnecessary medical barriers to contraception: celebrating a decade of the U.S. Medical Eligibility Criteria for Contraceptive Use","volume":"30","author":"Curtis KM","year":"2021","unstructured":"Curtis KM, Zapata LB, Pagano HP, Nguyen A, Reeves J, Whiteman MK. Removing unnecessary medical barriers to contraception: celebrating a decade of the U.S. Medical Eligibility Criteria for Contraceptive Use. J Womens Health (Larchmt). 2021, 30:293-300. 10.1089\/jwh.2020.8910","journal-title":"J Womens Health (Larchmt)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.10.032","article-title":"Shortcomings and disparities in contraception counseling and use by hypertensive individuals at risk for unintended pregnancy: a comparative analysis of the National Survey of Family Growth","volume":"230","author":"Danvers AA","year":"2024","unstructured":"Danvers AA, Gurney EG, Panushka KA, Peskin M, Evans TA. Shortcomings and disparities in contraception counseling and use by hypertensive individuals at risk for unintended pregnancy: a comparative analysis of the National Survey of Family Growth. Am J Obstet Gynecol. 2024, 230:350.e1-11. 10.1016\/j.ajog.2023.10.032","journal-title":"Am J Obstet Gynecol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202308150","article-title":"Contraception","volume":"176","author":"Cannon R","year":"2023","unstructured":"Cannon R, Treder K, Woodhams EJ. Contraception. Ann Intern Med. 2023, 176:ITC113-28. 10.7326\/AITC202308150","journal-title":"Ann Intern Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.7326\/M22-1485","article-title":"Contraceptive counseling: an essential component of preventive health care","volume":"175","author":"Laine C","year":"2022","unstructured":"Laine C. Contraceptive counseling: an essential component of preventive health care. Ann Intern Med. 2022, 175:1043-4. 10.7326\/M22-1485","journal-title":"Ann Intern Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2020.8905","article-title":"Contraceptive use among women in the United States aged 18-44 years with selected medical contraindications to estrogen","volume":"31","author":"Erly SJ","year":"2022","unstructured":"Erly SJ, Forward TR, Rogers ZH, Hawes SE, Micks E. Contraceptive use among women in the United States aged 18-44 years with selected medical contraindications to estrogen. J Womens Health (Larchmt). 2022, 31:580-5. 10.1089\/jwh.2020.8905","journal-title":"J Womens Health (Larchmt)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471496-contraception-in-women-with-medical-comorbidities-clinical-risk-stratification-and-individualized-therapeutic-strategies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:00:32Z","timestamp":1773324032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471496-contraception-in-women-with-medical-comorbidities-clinical-risk-stratification-and-individualized-therapeutic-strategies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.105102","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}